Other peptides that have been used for pulsing of moDCs for ovarian cancer are, for example, p53 peptide [105], Wilm’s Tumor 1 (WT1) peptide [106], a combination of Her-2/neu and mucin 1 [107] or a combination of hTERT, Her-2/neu, and PADRE peptides [108]. Here, ERBB2 is linked to ovarian cancer.